172 related articles for article (PubMed ID: 28702770)
1. Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).
McCartan DP; Zabor EC; Morrow M; Van Zee KJ; El-Tamer MB
Ann Surg Oncol; 2017 Oct; 24(11):3141-3147. PubMed ID: 28702770
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI
Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
[TBL] [Abstract][Full Text] [Related]
4. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
Pilewskie M; Jochelson M; Gooch JC; Patil S; Stempel M; Morrow M
J Am Coll Surg; 2016 Feb; 222(2):138-45. PubMed ID: 26711795
[TBL] [Abstract][Full Text] [Related]
5. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.
Vlastos G; Jean ME; Mirza AN; Mirza NQ; Kuerer HM; Ames FC; Hunt KK; Ross MI; Buchholz TA; Buzdar AU; Singletary SE
Ann Surg Oncol; 2001 Jun; 8(5):425-31. PubMed ID: 11407517
[TBL] [Abstract][Full Text] [Related]
7. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
8. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
9. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
[TBL] [Abstract][Full Text] [Related]
12. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
[TBL] [Abstract][Full Text] [Related]
13. Ipsilateral nodal recurrence after axillary dissection for breast cancer.
Walsh N; Kiluk JV; Sun W; Khakpour N; Laronga C; Lee MC
J Surg Res; 2012 Sep; 177(1):81-6. PubMed ID: 22498028
[TBL] [Abstract][Full Text] [Related]
14. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
15. No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
Vapiwala N; Hwang WT; Kushner CJ; Schnall MD; Freedman GM; Solin LJ
Cancer; 2017 Apr; 123(8):1324-1332. PubMed ID: 27984658
[TBL] [Abstract][Full Text] [Related]
16. Occult breast carcinoma presenting with axillary lymph node metastases.
Medina-Franco H; Urist MM
Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889
[TBL] [Abstract][Full Text] [Related]
17. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
Morrow M; Van Zee KJ; Patil S; Petruolo O; Mamtani A; Barrio AV; Capko D; El-Tamer M; Gemignani ML; Heerdt AS; Kirstein L; Pilewskie M; Plitas G; Sacchini VS; Sclafani LM; Ho A; Cody HS
Ann Surg; 2017 Sep; 266(3):457-462. PubMed ID: 28650355
[TBL] [Abstract][Full Text] [Related]
18. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Prognoses according to Breast MRI Results in Patients with Axillary Lymph Node Metastases from an Unknown Primary Origin.
Choi ER; Woo OH; Ko EY; Han BK; Choi JS; Ko ES; Kim H; Kim MK; Lee JE
Yonsei Med J; 2023 Oct; 64(10):633-640. PubMed ID: 37727923
[TBL] [Abstract][Full Text] [Related]
20. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
